ArticleJournal of medicinal chemistry2024

Discovery of GLPG2737, a Potent Type 2 Corrector of CFTR for the Treatment of Cystic Fibrosis in Combination with a Potentiator and a Type 1 Co-corrector.

Mathieu Pizzonero et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.